Electrochemiluminescence biosensor based on molybdenum disulfide-graphene quantum dots nanocomposites and DNA walker signal amplification for DNA detection

Based on the prominent electrochemiluminescence (ECL) performances of molybdenum disulfide-graphene quantum dots (MoS 2 -GQDs) nanocomposite and combined with enzyme-assisted recycling DNA walker signal amplification, an “on-off” switch ECL biosensor was proposed for sensitive assay of specific DNA...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Mikrochimica acta (1966) 2021-10, Vol.188 (10), p.353, Article 353
Hauptverfasser: Sun, Yina, Huang, Chuan, Sun, Xiujin, Wang, Qian, Zhao, Peini, Ge, Shenguang, Yu, Jinghua
Format: Artikel
Sprache:eng
Schlagworte:
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
Beschreibung
Zusammenfassung:Based on the prominent electrochemiluminescence (ECL) performances of molybdenum disulfide-graphene quantum dots (MoS 2 -GQDs) nanocomposite and combined with enzyme-assisted recycling DNA walker signal amplification, an “on-off” switch ECL biosensor was proposed for sensitive assay of specific DNA sequences. Noticeably, MoS 2 with two-dimensional nanosheet structure increased the loading capacity of GQDs to support abundant hairpin DNA (H). The composites of MoS 2 and GQDs facilitated the charge transfer in ECL process, which significantly improved the ECL signal to achieve an “on” state. Then, the DNA walker cyclic amplification was performed by adding the target DNA and exonuclease III (Exo III). Finally, the DNA2-Fc-DNA1 was introduced into the system as ECL signal quencher, turning the ECL signal into an “off” state. The sensitive assay of ultra-low concentration specific DNA sequences was realized according to the variation of ECL signal strength before and after the existence of target DNA. The proposed ECL biosensor showed a good linear relationship ranging from 1 nM to 100 aM with a detection limit of 25.1 aM, providing a powerful strategy for biomedical research and clinical analysis. Graphical abstract
ISSN:0026-3672
1436-5073
1436-5073
DOI:10.1007/s00604-021-04962-3